Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World’s Deadliest ‘Superbugs’

San Diego, Calif., March 30, 2017 – Forge Therapeutics, Inc., [...]

2017-03-30T15:19:10-07:0003.30.2017|Press Releases|
Go to Top